<?xml version="1.0" encoding="UTF-8"?>
<p id="Par52">Patients with Cushing’s disease, but particularly those under supraphysiologic doses of steroids [
 <xref ref-type="bibr" rid="CR79">79</xref>] may be also at a higher risk of COVID-19 infection because of the steroids potential immunosuppressive action. This issue is important, as around 5% of the world’s population is taking chronic corticosteroids and there is a high prevalence of AI among these patients [
 <xref ref-type="bibr" rid="CR80">80</xref>]. In these cases, under empiric principles, it might be recommendable to follow the same rules as patients with adrenal insufficiency.
</p>
